Measure the activity of the sympathetic, the parasympathetic nervous system with every heartbeat and the balance trajectory between them. Use the ANSiscope to monitor Chronic pain

Home
The Company
Products
Technology
Applications
Faq
Newsletters
Posters & Presentations
Publications
Press Coverage
Info for Doctors
Info for Patients
Info for Researchers
Info for Distribution Partners
Info for OEMs
Info for Investors
Links
Contact Us
ANS Forum










 

DyAnsys has pioneered a revolutionary Heart Rate Variability (HRV) device called the ANSicope that is accurate in monitoring the Autonomic Nervous System (ANS) at the heart beat level in real-time. This device uses a sophisticated mathematical analysis of the EKG to assess the ANS and how well the two subsystems (the sympathetic system and the parasympathetic system) work together. The ANSiscope is a safe, portable, non-invasive monitoring device that is ideal for use in hospitals, physicians” practices or in the field.

Hundreds of ANSiscopes have been sold since 2005 and doctors have measured over 100,000 diabetic patients. The cumulative experience of these doctors has been published in a document titled “The Detection and Treatment of Autonomic Neuropathy.” For a free copy of this document, please contact us at customer.contact@dyansys.com.

The ECScope Series of products represents breakthrough thinking in EKG machines. Affordably priced, the ECScope products are 10 lead, 12 channel devices that are handheld, portable, provide a letter/A4 size printout on inexpensive computer printers. Unlike other manufacturers, the ECScopes do not overly filter the EKG outputs, which could mask subtle abnormalities in the patient’s heart, and thus, hinder proper patient treatment. Contract us for a free demonstration in your office.

Product Specification
Portable ANSiscope ECScope Series

Reimbursement
The HRV measurements provided by the ANSiscope are reimbursable in the US through Medicare and most other major health care providers when billed using the CPT Code 95921..

 

 

News and Events
American Diabetes Association Recommends screening for Autonomic Neuropathy
 
Screening for autonomic neuropathy should be instituted at diagnosis of type 2 diabetes and 5 years after the diagnosis of type 1 diabetes
 
American Diabetes Association (ADA), Standard of Medical care in Diabetes, 2006
 
Dyansys introduces Portable ECScope for general physicians/ primary care providers
 
Dyansys gains ISO 13485:2003 certification for Portable ANSiscope, Portable ECScope
 

Dyansys is pleased to announces that European office has granted patent on ANSiscope technology for Germany, France & UK countries. Patent Number - 163947

 
Portable ANSiscope approved for FDA Certification
 
Portable ECScope approved for FDA Certification
Dyansys Product Family
The Portable ANSiscope and ECScope Series for family physicians and field applications 
The P-STIM neurostimulation device for treatment of chronic pain
  more  
Dyansys Application
Chronic & Acute Pain
Anesthesiology
Cardiology
Diabetes
Fetal Heart Monitoring
Measurement of autonomic dysfunction
  more  
Copyright © 2009 DyAnsys Inc. All Rights Reserved
Site designed by Uditi Technologies